Compounds for inhibition of α4 β7 integrin
US11578069B2 · kind B2 · utility
1Cited by
16References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 2020 |
| Grant date | Feb 14, 2023 |
| Priority date | — |
| Expiry date | Aug 12, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/052
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), therapeutic methods for treating inflammatory disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.